- Home
- RYTM vs AXS Comparison
RYTM vs AXS Comparison
Compare RYTM & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RYTM | AXS |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.4B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | RYTM | AXS |
|---|---|---|
| Price | $104.75 | $99.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $118.46 | $116.50 |
| AVG Volume (30 Days) | ★ 684.8K | 597.7K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | N/A | ★ 68.27 |
| EPS | N/A | ★ 12.10 |
| Revenue | $174,334,000.00 | ★ $6,301,015,000.00 |
| Revenue This Year | $46.10 | $6.70 |
| Revenue Next Year | $63.02 | $7.57 |
| P/E Ratio | ★ N/A | $8.30 |
| Revenue Growth | ★ 54.92 | 5.59 |
| 52 Week Low | $45.91 | $83.90 |
| 52 Week High | $116.00 | $107.19 |
Technical Indicators
Market Signals| Indicator | RYTM | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 51.15 | 51.64 |
| Support Level | $101.00 | $99.30 |
| Resistance Level | $110.00 | $102.68 |
| Average True Range (ATR) | 4.61 | 1.80 |
| MACD | 0.29 | -0.18 |
| Stochastic Oscillator | 63.89 | 8.27 |
Price Performance
Historical ComparisonAbout RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.